Mesa Laboratories (MLAB) Equity Average (2011 - 2025)

Mesa Laboratories (MLAB) has 15 years of Equity Average data on file, last reported at $182.6 million in Q4 2025.

• Quarterly Equity Average rose 15.31% year-over-year to $182.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $182.6 million (up 15.31% YoY) and the FY2025 annual result came in at $152.6 million, down 43.36% from the prior year.
• Equity Average improved to $182.6 million in Q4 2025 per MLAB's latest filing, from $175.5 million in the prior quarter.
• The five-year high for Equity Average was $409.5 million in Q1 2021, with the low at $148.1 million in Q2 2024.
• Average Equity Average over 5 years is $306.6 million, with a median of $383.9 million recorded in 2022.
• Year-over-year, Equity Average surged 79.9% in 2021 and sank 62.09% in 2024.
• Mesa Laboratories' Equity Average stood at $397.9 million in 2021, then fell by 4.31% to $380.7 million in 2022, then grew by 3.85% to $395.4 million in 2023, then plunged by 59.95% to $158.3 million in 2024, then climbed by 15.31% to $182.6 million in 2025.
• Business Quant data shows MLAB's Equity Average at $182.6 million in Q4 2025, $175.5 million in Q3 2025, and $166.2 million in Q2 2025.